Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Aranesp Overdose

An Aranesp overdose may potentially cause blood clots, congestive heart failure, strokes, or heart attacks. These effects usually occur when red blood cells increase too much or too quickly. If red blood cells increase too much during treatment with Aranesp, overdose treatment may involve removing blood. Treatment may also include supportive care, which consists of treating symptoms that occur as a result of the overdose.

Aranesp Overdose: An Introduction

Aranesp® (darbepoetin alfa) is a prescription medication used to treat anemia. It belongs to a group of medications known as erythropoiesis-stimulating agents (ESAs). The effects of an Aranesp overdose will vary depending on a number of factors, including the Aranesp dosage and whether it was taken with any other medicines, alcohol, or street drugs. If you happen to overdose on Aranesp, seek immediate medical attention.
 

Aranesp Overdose Symptoms

Aranesp works by stimulating the production of red blood cells. The expected symptoms of an Aranesp overdose are caused by the red blood cells increasing too quickly or too much. This can be very dangerous, increasing the risk of the following effects:
 

Treatment for an Aranesp Overdose

If the red blood cells increase too much, this can be corrected by removing blood. This is just the same process as donating blood (except the blood is not donated). Treatment may also include supportive care, which consists of treating the symptoms that occur as a result of the overdose.
 
The Zen of Cancer Caregiving - Recharge Your Batteries!

Aranesp Injection -- Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.